{
 "as_of": "2026-11-06",
 "cmr": "ca-cm-kg/TSXV/TLT",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Theralase Technologies Inc. (TSXV: TLT) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Theralase Technologies Inc., listed on the TSXV under ticker TLT. Its ISIN is CA88337V1004 and its LEI is 529900NI3Y8GLE2IBF28. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 15 filings in the twelve months to 2026-11-06, across 14 filing days. The median gap between filing days is 21 days. The latest filing is dated 2026-10-27, a newswire release, and it sits 10 days before the record date. The TSXV exchange median is 9 filings, a 19-day cadence gap and 17.0 days of latency; the Life Sciences sector median is 7.0 filings, a 17.5-day cadence gap and 14 days of latency. The issuer's filings count is above the exchange median and above the sector median, and its cadence gap is above the exchange median and above the sector median.\n\n## Auditor\n\nThe auditor of record is AGT Partners LLP, with its location not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds one lifecycle line, a listing dated 2026-06-05, with no delisting, name change, domicile change or segment move. The halt flag is listed, not halted.\n\n## Orderability\n\nFor client category paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. For client category paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's own investor-relations page; the count is 0.\n\n## Open research\n\nNo openly published research notes were found on the record; the count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. The issuer has no sealed years on the record. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)\n- https://cn.investing.com/equities/theralase-technologies-inc (identity.isin)\n- https://api.gleif.org/api/v1/lei-records/529900NI3Y8GLE2IBF28 (identity.jurisdiction)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSXV/TLT (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://theralase.com/wp-content/uploads/2024/05/Theralase-Management-Information-Circular-2025-AGM-meeting-Final.pdf (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/TSXV/TLT (the record)\n",
 "market": "CA",
 "node": "ca-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-10",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "adjudicated by Claude",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://theralase.com/wp-content/uploads/2024/05/Theralase-Management-Information-Circular-2025-AGM-meeting-Final.pdf",
    "state": "filled",
    "value": "AGT Partners LLP"
   },
   "auditor_firm_id": {
    "market": "CA",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CA",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "ca-cm-kg/TSXV/TLT",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://theralase.com/investors-and-media/",
     "result": "read: 0 of 2 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1427,
     "median_cadence_gap_days": 19,
     "median_filings": 9,
     "median_latency_days": 17,
     "name": "TSXV"
    },
    "sector": {
     "issuers": 200,
     "median_cadence_gap_days": 17.5,
     "median_filings": 7,
     "median_latency_days": 14,
     "name": "Life Sciences"
    }
   },
   "by_type": {
    "corporate_action": 1,
    "exchange_bulletin": 6,
    "halt_resume": 1,
    "newswire_release": 7
   },
   "cadence_median_gap_days": 21,
   "filing_days": 14,
   "filings": 15,
   "latency_days": 10,
   "latest": [
    {
     "category": null,
     "date": "2026-10-27",
     "source": "https://www.newsfilecorp.com/release/320824/Theralase-Provides-Bladder-Cancer-Clinical-Study-Update",
     "title": "Theralase Provides Bladder Cancer Clinical Study Update",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-26",
     "source": "https://www.newsfilecorp.com/release/320824/Theralase-Provides-Bladder-Cancer-Clinical-Study-Update",
     "title": "Theralase Provides Bladder Cancer Clinical Study Update",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-09",
     "source": "https://www.newsfilecorp.com/release/318110/TheralaseR-to-Present-at-ThinkEquity-Conference",
     "title": "Theralase(R) to Present at ThinkEquity Conference",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-15",
     "source": "https://www.newsfilecorp.com/release/314313/TheralaseR-Commences-GLP-Toxicology-Analysis-of-RutherrinR",
     "title": "Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-04",
     "source": "http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=321086&CORRECTION_FLG=N&HC_FLAG1=checked",
     "title": "TSXV bulletin: PP-B (Financings that are not done thru an Exchange Offering Prospectus)",
     "type": "exchange_bulletin"
    }
   ],
   "latest_filing_date": "2026-10-27",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ca-cm-kg.ai/events/TSXV/TLT",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "TSXV"
   },
   "isin": {
    "read_by": "Tavily search + regex extraction from page text",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://cn.investing.com/equities/theralase-technologies-inc",
    "state": "sourced",
    "value": "CA88337V1004"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column) · adjudicated by Claude",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/529900NI3Y8GLE2IBF28",
    "state": "filled",
    "value": "Canada (federal, CBCA)"
   },
   "lei": {
    "read_by": "GLEIF name-exact",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/529900NI3Y8GLE2IBF28",
    "state": "filled",
    "value": "529900NI3Y8GLE2IBF28"
   },
   "name": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "Theralase Technologies Inc."
   },
   "sector": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Life Sciences"
   },
   "security_type": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CA",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "TLT"
   },
   "website": {
    "market": "CA",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": [],
   "listing": [
    {
     "date": "2026-06-05",
     "source": "http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=318586&CORRECTION_FLG=N&HC_FLAG1=checked",
     "title": "TSXV bulletin: NEW LISTING-WARRANTS (New Listings)"
    }
   ],
   "name_change": [],
   "segment_move": []
  },
  "market": "CA",
  "node": "ca-cm-kg",
  "numbers_hash": "sha256:2c9c5812f23e56dfb66b8c47b580954df4a0d22da4a9ae74c405663bc1b48870",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Paragraph (o) of the definition",
    "Paragraph (q) of the definition"
   ],
   "outcomes": {
    "Paragraph (o) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "Paragraph (q) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ca-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1",
   "section": "ca.aio.v11"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ca-cm-kg.ai/record/TSXV/TLT",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:2c9c5812f23e56dfb66b8c47b580954df4a0d22da4a9ae74c405663bc1b48870",
 "path": "/ca/TSXV/TLT",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Theralase Technologies Inc., listed on the TSXV under ticker TLT. Its ISIN is CA88337V1004 and its LEI is 529900NI3Y8GLE2IBF28. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 15 filings in the twelve months to 2026-11-06, across 14 filing days. The median gap between filing days is 21 days. The latest filing is dated 2026-10-27, a newswire release, and it sits 10 days before the record date. The TSXV exchange median is 9 filings, a 19-day cadence gap and 17.0 days of latency; the Life Sciences sector median is 7.0 filings, a 17.5-day cadence gap and 14 days of latency. The issuer's filings count is above the exchange median and above the sector median, and its cadence gap is above the exchange median and above the sector median.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is AGT Partners LLP, with its location not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds one lifecycle line, a listing dated 2026-06-05, with no delisting, name change, domicile change or segment move. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For client category paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. For client category paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's own investor-relations page; the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record; the count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. The issuer has no sealed years on the record. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*"
  },
  {
   "for": "identity.isin",
   "source": "https://cn.investing.com/equities/theralase-technologies-inc"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/529900NI3Y8GLE2IBF28"
  },
  {
   "for": "identity.sector",
   "source": "https://www.tsx.com/en/resource/571"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ca-cm-kg.ai/events/TSXV/TLT"
  },
  {
   "for": "the halt flag",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100"
  },
  {
   "for": "the auditor",
   "source": "https://theralase.com/wp-content/uploads/2024/05/Theralase-Management-Information-Circular-2025-AGM-meeting-Final.pdf"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ca-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.ca-cm-kg.ai/record/TSXV/TLT"
  }
 ],
 "title": "Theralase Technologies Inc. (TLT) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}